Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peptide–Drug Conjugates: An Emerging Direction for the Next Generation of Peptide Therapeutics
Trevor T. Dean, Juliet Jelú-Reyes, A’Lester C. Allen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 1641-1661
Closed Access | Times Cited: 21

Showing 21 citing articles:

Recent Advances in Targeted Cancer Therapy: Are PDCs the Next Generation of ADCs?
Baochen Zhang, Mo Wang, Li Sun, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11469-11487
Closed Access | Times Cited: 8
Design and Synthesis of Isatin Derivative Payloaded Peptide-Drug Conjugate as Tubulin Inhibitor against Colorectal Cancer
Guoyang Sun, Zhao‐Yang Wang, Yanping Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117276-117276
Closed Access
Current Trends in Clinical Trials of Prodrugs
Diogo Boreski, Volkmar H.R. Schmid, Priscila Longhin Bosquesi, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 210-210
Open Access
Innovative design concepts in tumor-targeting peptide-drug conjugates: Insights into emerging applications
Ruirong Tan, Zhenya Yang, Xie Jun, et al.
Chinese Medical Journal (2025)
Open Access
Chemical Process Development in the Pharmaceutical Industry in Europe—Insights and Perspectives from Industry Scientists
Joachim I. Krueger, André P. Dieskau, Jorma Hassfeld, et al.
Angewandte Chemie International Edition (2025)
Open Access
Synthesis and Reactivity of Oligo(ethylene glycol)-Tethered Morita–Baylis–Hillman Dimers in the Formation of Macrocyclic Structures Showing Remarkable Cytotoxicity
Marco Paolino, M. Saletti, Jacopo Venditti, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 473-473
Closed Access
Chemical Process Development in the Pharmaceutical Industry in Europe—Insights and Perspectives from Industry Scientists
Joachim I. Krueger, André P. Dieskau, Jorma Hassfeld, et al.
Angewandte Chemie (2025)
Open Access
Precision peptide disruptors: The next generation of targeted therapeutics in oncology
Bria O'Gorman, Sean F. Cooke, Connor M. Blair
Cellular Signalling (2025), pp. 111783-111783
Open Access
M01 tool: an automated, comprehensive computational tool for generating small molecule-peptide hybrids and docking them into curated protein structures
Mahsa Sheikholeslami, Mohammad Nazari, Afshin Fassihi
BMC Bioinformatics (2025) Vol. 26, Iss. 1
Open Access
Current progress and remaining challenges of peptide–drug conjugates (PDCs): next generation of antibody-drug conjugates (ADCs)?
Dongyuan Wang, Feng Yin, Zigang Li, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Recent Advances in Augmenting the Therapeutic Efficacy of Peptide–Drug Conjugates
Jiahui Ma, Xuedan Wang, Yong-hua Hu, et al.
Journal of Medicinal Chemistry (2025)
Open Access
Systemic study on anti-tumor activity of HER2 induced peptide-drug conjugate clustering in xenograft tumor models
Qinghua Chen, Da‐Yong Hou, Ni‐Yuan Zhang, et al.
Chinese Chemical Letters (2025), pp. 111257-111257
Closed Access
Two Step Synthesis of Octreotide-doxorubicin Conjugates Based on Disulfide Bond Linker
Qian-Yao Yu, Ming Meng, Jing-Fang Yao, et al.
Acta Chimica Sinica (2025) Vol. 83, Iss. 4, pp. 341-341
Closed Access
Peptide–Drug Conjugates as Next-Generation Therapeutics: Exploring the Potential and Clinical Progress
Krishna Jadhav, Ashwin Abhang, Eknath Kole, et al.
Bioengineering (2025) Vol. 12, Iss. 5, pp. 481-481
Open Access
Exploring the Utility of Cell‐Penetrating Peptides as Vehicles for the Delivery of Distinct Antimalarial Drug Cargoes
Caitlin L. Gare, Isabella R. Palombi, Andrew M. White, et al.
ChemMedChem (2024)
Closed Access | Times Cited: 2
A General Nitrene Transfer to Sulfides Enabled by Visible-Light-Mediated Triplet Energy Transfer to Sulfonyl Azides
Norihito Arichi, Tsuyoshi Amano, Shuhan Wu, et al.
(2024)
Open Access | Times Cited: 1
A General Nitrene Transfer to Sulfides Enabled by Visible-Light-Mediated Triplet Energy Transfer to Sulfonyl Azides
Norihito Arichi, Tsuyoshi Amano, Shuhan Wu, et al.
(2024)
Open Access | Times Cited: 1
Synthesis of Sulfilimines via Visible‐Light‐Mediated Triplet Energy Transfer to Sulfonyl Azides
Norihito Arichi, Tsuyoshi Amano, Shuhan Wu, et al.
Chemistry - A European Journal (2024) Vol. 30, Iss. 48
Closed Access | Times Cited: 1
Celebrating the 60th Anniversary of the MIKIW Meeting-in-Miniature: Virtual Special Issue
Terry W. Moore, William C. K. Pomerantz
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 6895-6896
Open Access
Celebrating the 60th Anniversary of the MIKIW Meeting-in-Miniature: Virtual Special Issue
Terry W. Moore, William C. K. Pomerantz
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 5, pp. 565-566
Open Access
A PD-L1 tropism-expanded oncolytic adenovirus enhanced gene delivery efficiency and anti-tumor effects
Shengsheng Mei, Shanshan Peng, Eu Gene Vong, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112393-112393
Closed Access
An ensemble method for predicting and designing of druggable proteins.
Shipra Jain, Srijanee Gupta, Gajendra P. S. Raghava
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Phage Power: Harnessing Nature’s Arsenal in the Battle Against Microbial Threats for Sustainable Healthcare
Jyotirmayee, Reshma Khanda, Malkhey Verma
(2024), pp. 685-716
Closed Access
Page 1

Scroll to top